Acute Repiratory Distress Syndrome in cancer patients: Epidemiology, risk factors and outcomes
Keywords:
Respiratory Distress Syndrome, Adult, Cancer, Intensive Care Unit, Mortality.Abstract
Purpose: This study aimed to evaluate the incidence and outcomes of Acute Respiratory Distress Syndrome (ARDS) in adult oncological patients in the ICU of a dedicated cancer hospital, as well as analyse the risk and protective factors associated with mortality in this population. Methods: A prospective cohort study evaluating all adult cancer patients admitted to the ICU, from January 2012 to December 2013. Results: The incidence of ARDS (n=87) was 11.9% of cancer patients in the ICU, and 17.8% among those in mechanical ventilation. ARDS was more common in onco-hematological patients. Patients with ARDS had longer ICU length of stay, more complications (mainly acute kidney injury [AKI]) and mortality than non-ARDS patients. Among patients with ARDS, those with a later ARDS onset (>48 h hospitalised) and with a more positive Fluid Balance (FB) had a higher mortality incidence. No differences were found in the ventilatory parameters, although the patients who died presented reduced pulmonary static compliance. Conclusions: The incidence and morbimortality of ARDS were high (particularly in onco-hematological patients). Later onset ARDS and highly positive FB presented a trend to a higher mortality.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.